Coronary Stents Market to Exceed $7.2 Billion by 2012, According to New Report by Global Industry Analysts, Inc.

Share Article

Coronary stents, one of the fastest growing categories in the global medical device industry, registered rapid growth due to rapid advancements in the area of drug-eluting stents. Driven by the introduction of Drug Eluting Stents (DES) in 2002, the market for coronary stents is slated to exceed $7.2 billion by 2012.

Coronary Stents: A Global Strategic Business Report

Aging populace, enhanced availability of sophisticated stents, rising patient affluence and affordability, and growing awareness are factors propelling growth of coronary stents. Advances in technology and novel formulations from new market entrants, have significantly contributed to market growth. Thorny regulatory barriers in certain countries such as Japan continue to plague the industry leading to higher product prices. Improvement in cardiac care resulting in greater number of positive outcomes of coronary stenting will also lead to market expansion.

Backed by higher number of angioplasty procedures, high awareness levels, greater penetration and existence of well-established players, United States represents the largest market for coronary stents worldwide. The US market is estimated at close to US$2.2 billion in 2008 as stated by Global Industry Analysts, Inc. Europe is the second largest market followed by Japan at third position. Collectively, the US, Europe and Japan account for about 85% of the global coronary stents market. Bare metal stents, a declining market in the current scenario, is projected to be worth US$1.5 billion in 2012. The drug eluting stents market is forecast to reach a value of US$5.7 billion in 2012.

The bare metal stents market is fairly concentrated in terms of structure with the top four players taking the lion's share. Participants in the overall market include Angiotech Pharmaceuticals, Boston Scientific, Cordis, Cook Group, Medtronic, Medtronic, MIVI Technologies, OrbusNeich, Sorin Biomedica and Sun Biomedical.

"Coronary Stents: A Global Strategic Business Report" published by Global Industry Analysts, Inc., provides a comprehensive review of market trends, drivers, product profile, players, competition, research and development, regulatory approvals, recent developments, mergers, acquisitions, and other strategic industry activities. Analysis is presented for major geographic markets such as United States, Japan, France, Germany, the UK, Italy, Spain, Asia, and rest of world. Analytics are provided in terms of product segments including Bare Metal Stents and Drug Eluting Stents.

For more details about this research report, please visit http://www.strategyr.com/Coronary_Stents_Market_Report.asp.

About Global Industry Analysts, Inc.:
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 700 people worldwide and publishes more than 880 full-scale research reports each year. Additionally, the company also offers a range of over 60,000 smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.
Telephone 408-528-9966
Fax 408-528-9977
Email press @ strategyR.com
Web Site http://www.StrategyR.com/

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Public Relations
Visit website